Chemotherapy for frail and elderly patients (pts) with advanced gastroesophageal cancer (aGOAC): Quality of Life (QoL) results from the GO2 phase III trial

Hall, P, Swinson, D, Lord, S et al. (7 more authors) (2019) Chemotherapy for frail and elderly patients (pts) with advanced gastroesophageal cancer (aGOAC): Quality of Life (QoL) results from the GO2 phase III trial. In: 44th ESMO Congress (ESMO 2019), 27 Sep - 01 Oct 2019, Barcelona, Spain.

Metadata

Authors/Creators:
Dates:
  • Published: October 2019
Institution: The University of Leeds
Funding Information:
FunderGrant number
Cancer Research UKA14923
Depositing User: Symplectic Publications
Date Deposited: 26 Nov 2020 14:59
Last Modified: 26 Nov 2020 14:59
Status: Published
Identification Number: https://doi.org/10.1093/annonc/mdz394.037
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)